NP
CME icon

Ninepoint Partners’s CME Group CME Stock Holding History

Ninepoint Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-864
Closed -$255K – 171
2026
Q1 		$255K Sell
864
-1,587
-65% -$471K 0.02% 129
2025
Q4 		$669K Buy
2,451
+331
+16% +$89.9K 0.07% 90
2025
Q3 		$573K Hold
2,120
– – 0.08% 85
2025
Q2 		$584K Hold
2,120
– – 0.1% 82
2025
Q1 		$562K Hold
2,120
– – 0.09% 85
2024
Q4 		$492K Hold
2,120
– – 0.07% 87
2024
Q3 		$468K Hold
2,120
– – 0.05% 83
2024
Q2 		$417K Hold
2,120
– – 0.04% 78
2024
Q1 		$456K Hold
2,120
– – 0.05% 78
2023
Q4 		$446K Hold
2,120
– – 0.05% 67
2023
Q3 		$424K Hold
2,120
– – 0.04% 69
2023
Q2 		$393K Buy
+2,120
New +$392K 0.04% 68

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Ninepoint Partners's CME Position: Q2 2026 in Review

Ninepoint Partners sold out of CME Group (CME) in Q2 2026, closing a stake of 864 shares — an estimated $255K sold.

Ninepoint Partners first reported a position in CME in Q2 2023 and held it in 12 quarters. The position peaked at $669K in Q4 2025. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Ninepoint Partners reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Ninepoint Partners sold 864 CME Group shares in Q2 2026, an estimated $255K.
  • Ninepoint Partners first reported a position in CME Group in Q2 2023 and held it in 12 quarters.
  • Ninepoint Partners's CME Group position peaked at $669K in Q4 2025.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Ninepoint Partners's 13F filing for Q2 2026, filed 11 Aug 2026.